UK markets closed

AVROBIO, Inc. (AVRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2200-0.0100 (-0.81%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
47,700
47,700
72,186
83,114
87,236
Selling general and administrative
23,967
23,967
33,248
35,727
32,992
Total operating expenses
71,667
71,667
105,434
118,841
120,228
Operating income or loss
-71,667
-71,667
-105,434
-118,841
-120,228
Total other income/expenses net
81,781
81,781
-157
-61
-203
Income before tax
12,534
12,534
-105,890
-119,126
-119,712
Income tax expense
377
377
0
-
-
Income from continuing operations
12,157
12,157
-105,890
-119,126
-119,712
Net income
12,157
12,157
-105,890
-119,126
-119,712
Net income available to common shareholders
12,157
12,157
-105,890
-119,126
-119,712
Basic EPS
-0.10
-
-2.42
-2.78
-3.31
Diluted EPS
-0.10
-
-2.42
-2.78
-3.31
Basic average shares
44,124
-
43,739
42,854
36,206
Diluted average shares
44,267
-
43,739
42,854
36,206